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A key factor in the development of Type II diabetes is the loss of insulin producing pancreatic β-cells. The amyloidogenic human Islet
Amyloid Polypeptide (hIAPP also known as human amylin) is believed to play a crucial role in this biological process. Previous studies have
shown that hIAPP forms small aggregates that kill β-cells by disrupting the cellular membrane. In this study, we report membrane fragmentation
by hIAPP using solid-state NMR experiments on nanotube arrays of anodic aluminum oxide containing aligned phospholipid membranes. In a
narrow concentration range of hIAPP, an isotropic 31P chemical shift signal indicative of the peptide-induced membrane fragmentation was
detected. Solid-state NMR results suggest that membrane fragmentation is related to peptide aggregation as the presence of Congo Red, an
inhibitor of amyloid formation, prevented membrane fragmentation and the non-amyloidogenic rat-IAPP did not cause membrane fragmentation.
The disappearance of membrane fragmentation at higher concentrations of hIAPP suggests an alternate kinetic pathway to fibril formation in
which membrane fragmentation is inhibited.
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Amyloid Polypeptide (hIAPP) found in pancreatic β-cells to
the development of Type II Diabetes [1]. Soluble oligomers of
hIAPP have been shown to kill β-cells by binding to and
disrupting the cellular membrane [2–4]. Interestingly, other
amyloidogenic peptides such as Aβ, α-synuclein, and poly-
glutamine have also been found to cause cell death by a similar
mechanism [5]. Therefore, there is considerable interest in
investigating the interaction of amyloidogenic peptides with
phospholipid membranes.
Human-IAPP (also known as human amylin) has been
shown to be toxic to β-cells while the rat version of IAPP
(rIAPP) is known to be non-toxic [2–4]. A comparison of
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doi:10.1016/j.bbamem.2007.07.0012 diabetes and mammals such as rats that do not develop type 2
diabetes revealed important differences in a ten amino acid
stretch in the segment 20–29 (SNNFGAILSS in the human
sequence, SNNLGPVLPP in the rat sequence). This segment
has also been shown to be critical for the aggregation of the
peptides into amyloid fibers, studies have shown that this
fragment of hIAPP (hIAPP20–29) is amyloidogenic whereas the
20–29 fragment of rIAPP (rIAPP20–29) is non-amyloidogenic
[6–10]. Furthermore, full-length hIAPP containing proline
mutations in the 20–29 segment is rendered non-amyloido-
genic, illustrating the critical role of this sequence for
fibrilogenesis [8]. Like full-length hIAPP, hIAPP20–29 inserts
into lipid bilayers, albeit with a lower binding affinity and
without the preference for anionic lipids shown by full-length
hIAPP [11].
In this study, we report membrane fragmentation by the
amyloidogenic hIAPP20–29 fragment and not by the corresponding
Fig. 1. Phosphorus-31 chemical shift spectra of aligned DMPC bilayers
containing various mol% of IAPP in AAO nanotubes: (A) 0%, (B) 0.5%
hIAPP20–29, (C) 0.75% hIAPP20–29, (D) 1% hIAPP20–29, (E) 1% hIAPP20–29
after incubation for 48 h, (F) 1.25% hIAPP20–29, (G) 0.5% rIAPP20–29, (H) 1%
rIAPP20–29.
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hIAPP20–29 and rIAPP20–29 peptides were synthesized by standard
FMOCmethodswith an amidatedC-terminus and an acetylatedN-
terminus. Purity was measured as greater than 95% by analytical
HPLC and the sequence was verified by electrospray MAS.
Membrane fragmentation was detected by the presence of a
motionally averaged peak at the isotropic 31P chemical shift
frequency. Bilayers of DMPC (1,2-Dimyristoyl-sn-Glycero-3-
Phosphocholine)were used asmodelmembranes to investigate the
membrane interaction of hIAPP20–29 and rIAPP20–29. As
previously utilized in studies on antimicrobial peptides [12],
aligned phospholipid bilayers were used to determine the
mechanism of membrane disruption by IAPP. Since the
preparation of mechanically aligned bilayers takes several days
and the sample lacks bulk water, in this study, we chose to use
anodic aluminum oxide (AAO) nanotubes to rapidly align bilayers
with excess water. Previous studies have demonstrated that the
alignment of lipid bilayers in AAO nanotubes is suitable for solid-
state NMR experiments [13–15]. As described elsewhere, aligned
samples are useful to measure peptide-induced structural disorders
in lipid bilayers using solid-state NMR experiments [16].
To assess membrane fragmentation, AAO discs containing
4 mg of DMPC and between 0 and 4 mol% of either hIAPP20–29
or rIAPP20–29 were examined in increments of 0.25 mol%
peptide by 31P NMR. Samples for 31P NMR were prepared by
the deposition of multilamellar vesicles (MLVs) onto AAO
discs. MLV samples were prepared by mixing a stock solution
of the peptide in methanol (1 mg/ml) with 200 μl of a
choloroform solution of DMPC (20 mg/ml). The solvent was
removed from the peptide/lipid samples by first drying the
sample under a stream of nitrogen and then by drying under a
vacuum overnight to completely remove any residual solvent.
The resulting peptide/lipid film was directly hydrated with
70 μ of HEPES buffer (50 mM, pH 7.4) to form multilamellar
vesicles. The MLV sample was heated above the transition
temperature of DMPC and then pipetted onto a single 19 mm
radius AAO disc cut into 10 mm by 10 mm strips to fit into a
14×14×4 mm flat-coil probe. The sample was then sealed in a
plastic bag along with extra buffer (∼200 μl) to prevent
dehydration during signal acquisition. The lipid bilayers are
estimated to occupy approximately 14% of the pore volume in
the AAO nanotube array (the remainder is filled with buffer).
Representative 31P chemical shift spectra of DMPC bilayers
containing varying concentrations of hIAPP20–29 and rIAPP20–29
are shown in Fig. 1. To ensure reproducibility, spectra were
acquired for 3 independent samples at each concentration. The
spectra were acquired on a Chemagnetics/Varian 400 MHz
spectrometer using a flat-coil (14×14×4 mm) probe and a spin-
echo sequence (90°–τ–180°–τ,τ=60 μs) with the bilayer
normal perpendicular to the magnetic field at 37 °C. 31P spectra
were referenced relative to liquid H3PO4. For each sample 2048
transients were collected with a recycle delay of 3 s and 60 Hz
line broadening. The nanotube material itself has a broad
resonance (∼20 ppm wide) centered ∼10 ppm [15]. This signal
was subtracted for clarity.
A single peak at −13.0 ppm in the 31P chemical shift
spectrum is observed for pure lipids indicating an unperturbedlamellar phase lipid bilayer with a high degree of alignment in
the magnetic field (Fig. 1A) [13]. A low intensity broad signal
can be due to the unaligned lipids. A small shift of the main
peak (b0.5 ppm for hIAPP20–29 (Fig. 1B and C) and ∼3 ppm
for rIAPP20–29 (Fig. 1G and H)) was observed. This could
suggest that some of the peptides bind to the lipid head group
region, which could result in a change in the conformation of
the lipid head group as has been reported for other membrane
surface binding peptides [17]. The 31P spectra suggest that at
low (up to 0.75%) (Fig. 1B) and high (N1.25%) (Fig. 1F) mol%
of hIAPP20–29 lipid bilayers were in the lamellar phase with no
observable disorder induced by the peptide. However, within a
narrow range of hIAPP20–29 mol% (∼0.75% to 1.25%, Fig. 1C
and D), an isotropic peak near −1 ppm was observed suggesting
peptide-induced membrane fragmentation in lipid bilayers. A
slight deviation of this peak frequency from the isotropic
chemical shift and the line width (full width at half maximum
ranges from ∼630 to ∼1090 Hz) could be due to restricted
motion and/or residual alignment of bilayer fragments in
nanopores. The isotropic peak was still observable even after
incubation for 48 h or 1 week (Fig. 1E), but the lineshape
showed some variations. It should be noted that Congo Red
staining on large unilamellar vesicles incubated for 48 h
revealed the presence of amyloid formation (data not shown);
similar results have been reported in the literature [6]. On the
other hand, as seen from the representative 31P spectra (Fig. 1G
and H), the non-amyloidogenic rIAPP20–29 peptide did not
fragment lipid bilayers at any of the concentrations examined
(0.25 to 3 mol%).
Further confirmation of the presence of small vesicle-like
structures was obtained by dynamic light scattering measure-
ments. MLV peptide–lipid samples (10 mg) were prepared as
Fig. 3. A schematic model for membrane fragmentation by hIAPP20–29. (A) At
lower concentrations, the peptide aggregates on the lipid bilayer surface to form
an intermediate state that is capable of extracting phospholipid molecules from
the bilayer and leading to peptide–lipid vesicles (B). At higher concentrations,
fiber formation follows an alternate pathway bypassing the formation of this
intermediate (C).
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separated from the lipid pellet and the vesicle size in the
supernatant measured with a NICOMP 380 particle sizer. At 1%
peptide, the particles were determined to be polydisperse with
an average diameter of 103 nm and a polydispersity of 86 nm.
The approximate size of the vesicle-like structures is in
agreement with a previous report on the formation of similar
non-bilayer structures with the Aβ1–42 peptide although the
polydispersity is much greater [18]. No appreciable light
scattering was detected from the rIAPP20–29 samples or a
control lipid sample without peptide.
The absence of the isotropic 31P peak at higher concentra-
tions of hIAPP20–29 and the inability of non-amyloidogenic
rIAPP20–29 to fragment the membrane indicate that peptide
aggregation on the membrane plays a crucial role in this
process. To show the correlation between the aggregation of
hIAPP and membrane fragmentation, Congo Red was added to
the hydration buffer of the sample. Congo Red is known to
inhibit the formation of amyloid structure, most likely by
interfering with the π-stacking interactions between peptides
necessary for amyloidogenesis [19]. In contrast to some other
inhibitors such as rifampicin, Congo Red does not prevent the
binding of IAPP to the membrane [20]. As shown in Fig. 2,
Congo Red suppresses the isotropic peak formation, incom-
pletely at 2 mol% (Fig. 2B) and completely at 5 mol% (Fig. 2C)
of Congo Red. This suggests that the isotropic peak is related to
the potential of the peptide to form aggregates.
Remarkably, higher concentrations of hIAPP20–29 also
suppress membrane fragmentation (Fig. 1C and D). This is
surprising because the standard detergent-like model for
membrane fragmentation predicts membrane fragmentation
after a threshold peptide/lipid ratio is reached and an increase
in membrane fragmentation at higher peptide/lipid ratios [21].
Since membrane permeabilization in hIAPP and other amyloid
peptides is linked to the oligomeric state of the peptide, the lackFig. 2. 31P chemical shift spectra of DMPC bilayers containing 1 mol% of
hIAPP aligned in AAO nanotubes with varying concentrations of Congo Red.
(A) 0, (B) 2, and (C) 5 mol%. The isotropic peak, indicative of membrane
fragmentation, is suppressed in the presence of Congo Red (B and C).of membrane fragmentation at higher peptide/lipid ratios
suggests a different oligomeric state at higher peptide/lipid
ratios. It is well known that the kinetics of fiber formation and
the structures of amyloid fibers are dependent on the solution
conditions of fiber growth. Numerous studies of amyloid
proteins have shown the monomeric and fibrillar states of the
protein are non-cytotoxic, however, transient oligomeric
intermediates along the fibrilogenesis pathway show a strong
cytotoxicity [2–4]. If these cytotoxic intermediates along the
fibrilogenesis pathway are responsible for the membrane
fragmentation seen in Fig. 1C and D, the concentration of
intermediate states responsible for membrane fragmentation
may be reduced either through an alteration of the initial
distribution of hIAPP20–29 oligomeric states or a change in the
kinetic pathway of fiber formation to disfavor the formation of
cytotoxic oligomeric states at higher concentrations of
hIAPP20–29. Further studies are in progress to characterize the
lipid–peptide structures seen in Fig. 1C and D. A schematic of
possible pathways is illustrated in Fig. 3.
A different mechanism of membrane disruption by amyloid
proteins has been proposed in which lipid molecules are
extracted directly from the membrane into the nascent amyloid
fiber [22,23]. If detached from the membrane, the amyloid
fibers would tumble rapidly in solution and therefore the
phospholipid molecules trapped within the fibers would give
rise to a motionally averaged isotropic 31P signal. However, the
high percentage of lipid in the isotropic phase at relatively low
peptide/lipid ratios suggests this is not the mechanism primarily
responsible for membrane fragmentation under these experi-
mental conditions as it is unlikely the amyloid fiber can
incorporate such a large excess of lipid molecules.
In agreement with our findings, membrane lesions have been
detected in a previous study by atomic force microscopy upon
the addition of the amyloidogenic human form of IAPP but not
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[24]. However, the experimental setup used in that study could
not distinguish between membrane lesions caused by a peptide-
induced expansion of the bilayer and membrane lesions caused
by micellization of the lipid bilayer. Furthermore, the membrane
lesions caused by hIAPP spread from initial defects on the mica
surface, leaving open the question of the role of surface defects
on the mica surface in the membrane disruption process. In
contrast, solid-state 31P NMR spectroscopy directly detects the
loss of lamellar structure.
In summary, we have reported the direct detection of
membrane fragmentation by the main amyloidogenic fragment
of hIAPP using 31P solid-state NMR spectroscopy. One of the
hallmarks of hIAPP cytotoxicity is the partial fragmentation of
the cellular membrane into an abnormal mass of small vesicle-
like structures [4]. However, the existence of vesicle-like
structures in electron micrographs of cells is by itself not a
conclusive evidence for direct fragmentation of the cell
membrane by hIAPP. The presence of hIAPP in the cell may
indirectly induce membrane fragmentation by activating other
biochemical processes that lead to membrane fragmentation
[25]. However, the observation of membrane fragmentation in
model phospholipid membranes by hIAPP20–29 reported in this
study suggests that hIAPP may induce cytotoxicity by direct
fragmentation of the cellular membrane.
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